From Jorge D. Faccinetti, co-founder and chief editor: Why can’t we address some of the most critical issues affecting healthcare today? These are not just other people’s problems. They affect us, our doctors, and our
Advocacy Zone
For patient support groups and advocates to share their stories, best practices, collaborate and get involved.
Should we answer surveys, share our experiences, participate in drug trials, engage with others?
Joining a new drug trial, for example, is an action that can benefit many affected with a disease, particularly with a rare disease, where finding enough people for an adequate sample is very challenging.
A talk with Crinetics Chairman Scott Struthers, Ph.D.
During these trying times, work continues, even at a faster pace, for new drugs and therapies for pituitary patients. From the J D Faccinetti, co-founder – We recently caught up with Crinetics Pharmaceuticals chairman Dr.
A discussion on telemedicine and pituitary disease
Important changes in telehealth visit regulations provide an excellent opportunity for patients to receive consultations from highly experienced specialists in pituitary disease. Read on! On Monday, November 16, 2020, doctors Lewis Blevins and Sandeep Kunwar
The effects of COVID-19 on pituitary patients’ usage and access to healthcare
From J D Faccinetti and Lewis S Blevins, M.D. cofounders – Our focus today is on the effects of COVID-19 on pituitary patients’ access to, and utilization of healthcare as the pandemic continues to affect
On November 1 organizations around the world mark Acromegaly Day
Patients, advocacy, and healthcare organizations are promoting awareness of the condition around the world. The World Alliance of Pituitary Organizations WAPO Board decided to re-use the WAPO Acromegaly Awareness Campaign of 2019 to raise awareness on
A note on the importance of awareness
Tell us what is like to live with acromegaly From J D Faccinetti – co-founder and chief editor: In the awareness business, coming up with new, fresh, creative ideas is essential to get your message across,
Pituitary World News announces the launch of its Spanish edition
FOR IMMEDIATE RELEASE: PITUITARY WORLD NEWS ANNOUNCES THE LAUNCH OF ITS SPANISH EDITION – SAN FRANCISCO: August 26, 2020. Co-founders Lewis S. Blevins, Jr. M.D., and J D Faccinetti announced today the launch of Pituitary
Help improve acromegaly care around the world.
Acromegaly patients and healthcare providers worldwide can participate in this survey designed to provide information that may help improve quality of life during the COVID-19 pandemic. Much of this initiative’s success will depend on your
Education by the Experts: If you missed the live meeting, here’s there presentation
On June 7th the patient support and advocacy group Acromegaly Community hosted another online presentation in its series, “Education by the Experts”. Linda M. Rio, a frequent contributor to PWN, was featured at the Acromegaly Community’s
Things to think about: Coming up on Pituitary World News
From J D Faccinetti – co-founder – One of the unforeseen consequences of this crisis is how it has affected our editorial decisions, that is, deciding what to write and when to publish. The media
A word about comments
From the desk of J D Faccinetti Chairman, CEO and chief editor Pituitary World News. We recently published two COVID-19 related articles that focused on subjects that are very much in everyone’s mind. One was
Tumors and adenomas: “to NET or not to NET.”
From the desk of Jorge D. Faccinetti, Pituitary World News co-founder – There seems to be a debate going on in the scientific and clinical pituitary world about what to call pituitary adenomas. The simple interpretation